-
公开(公告)号:AT501141T
公开(公告)日:2011-03-15
申请号:AT04751135
申请日:2004-05-03
Applicant: ABBOTT LAB
Inventor: COWART MARLON , KU YIN-YIN , CHANG SOU-JEN , FERNANDO DILINIE , GRIEME TIMOTHY , ALTENBACH ROBERT
IPC: C07D417/04 , A61K31/404 , A61K31/425 , A61P25/00 , C07D209/14 , C07D235/10 , C07D235/14 , C07D263/56 , C07D277/64 , C07D279/16 , C07D401/04 , C07D403/04 , C07D403/06 , C07D405/04 , C07D413/06 , C07D417/06 , C07D417/14
Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions. X is O, S, NH, or N(alkyl); Y, and Y' are each independently selected from the group consisting of CH, CF, and N; Z is C or N, provided that when X is O or S, Z is N; one of R 1 and R 2 is selected from the group consisting of aryl, heteroaryl, and heterocycle; the other of R 1 and R 2 is selected from the group consisting of hydrogen, alkyl, alkoxy, aryl, cycloalkyl, halo, cyano, and thioalkoxy; R 3 is absent when Z is N and, when present, R 3 is selected from the group consisting of hydrogen, methyl, alkoxy, halo and cyano; R 4 and R 5 are each independently selected from the group consisting of alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, cycloalkyl, and cycloalkylalkyl, or R 4 and R 5 taken together with the nitrogen atom to which each is attached form a non-aromatic ring L is -[C(R 15 )(R 16 )]n-; m is an integer from 0-3; and n is an integer from 2-3. or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, wherein: X is O,S,NH,or N(alkyl); Y, and Y' are each independently selected from the group consisting of CH, CF, and N; Z is C or N, provided that when X is O or S, Z is N; one of R 1 and R 2 is selected from the group consisting of aryl, hetereoaryl, and heterocycle.
-
公开(公告)号:ES2360523T3
公开(公告)日:2011-06-06
申请号:ES04751135
申请日:2004-05-03
Applicant: ABBOTT LAB
Inventor: COWART MARLON , KU YIN-YIN , CHANG SOU-JEN , FERNANDO DILINIE , GRIEME TIMOTHY , ALTENBACH ROBERT
IPC: C07D417/04 , A61K31/404 , A61K31/423 , A61K31/425 , A61P25/00 , C07D209/14 , C07D235/10 , C07D235/14 , C07D263/56 , C07D277/64 , C07D279/16 , C07D401/04 , C07D403/04 , C07D403/06 , C07D405/04 , C07D413/06 , C07D417/06 , C07D417/14
Abstract: Un compuesto de formula: o una de sus sales, esteres, amidas, farmaceuticamente aceptables, donde: X es O, S, NH, o N(alquilo); Y, e Y' se seleccionan cada uno independientemente del grupo que consiste en CH, CF, y N; Z es N, uno de R1 y R2 se selecciona del grupo que consiste en arilo, heteroarilo, y heterociclo; el otro de R1 y R2 se selecciona del grupo que consiste en hidrogeno, alquilo, alcoxi, arilo, cicloalquilo, halo, ciano, y tioalcoxi; R3 esta ausente; R4 y R5 se seleccionan cada uno independientemente del grupo que consiste en alquilo, haloalquilo, hidroxialquilo, alcoxialquilo, cicloalquilo, y cicloalquilalquilo, o R4 y R5 tomados junto con el atomo de nitrogeno al que estan unidos cada uno forman un anillo no aromatico de estructura (a): R7, R8, R9, y R10 se seleccionan cada uno independientemente del grupo que consiste en hidrogeno, hidroxialquilo, fluoroalquilo, y alquilo; o uno del par R7 y R6 o el par R9 y R10 se toman juntos para formar un anillo C3-C6, donde 0, 1, o 2 heteroatomos seleccionados entre O, N, o S remplazan a un atomo de carbono en el anillo; R11 y R12 se seleccionan cada uno independientemente del grupo que consiste en hidrogeno, hidroxi, hidroxialquilo, alquilo, y fluor; R13 y R14 en cada aparicion se seleccionan independientemente del grupo que consiste en hidrogeno, alquilo, y fluor; L es -[C(R15)(R16)]n-; R15 y R16 en cada aparicion se seleccionan independientemente del grupo que consiste en hidrogeno, alquilo, alcoxi, y fluor; m es un numero entero de 0-3; y n es un numero entero de 2-3.
-
公开(公告)号:AT431735T
公开(公告)日:2009-06-15
申请号:AT03777773
申请日:2003-10-22
Applicant: ABBOTT LAB
Inventor: BENNANI YOUSSEF , CHANG SOU-JEN , CHEMBURKAR SANJAY , DART MICHAEL , FERNANADO DILINIE , GRIEME TIMOTHY
IPC: A61K31/19 , A61K31/33 , A61K31/397 , A61K31/401 , A61K31/495 , A61K31/537 , A61K31/54 , A61K31/55 , A61P25/08 , C07C61/13 , C07C61/135 , C07C61/29 , C07C69/753 , C07C233/58 , C07C237/22 , C07C237/24
Abstract: The present invention relates to the use of compounds of formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.
-
-